Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Steven D. Folkerth"'
Autor:
Charles P. Andrews, Luwy Musey, Richard E. Rupp, Chitrananda Abeygunawardana, Steven D. Folkerth, Richard D. McFetridge, Rocio D. Marchese, David Greenberg, Jon E. Stek, Susan Ermlich, Jonathan Hartzel
Publikováno v:
Vaccine. 36:6875-6882
Background Pneumococcal disease remains a public health priority in adults. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) containing 13 serotypes included in 13-valent pneumococcal conjugate vaccine (PCV13) plus 2 addi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd0c8732f4552c121867e81dbe8a2f9c
https://doi.org/10.1016/j.vaccine.2018.03.012
https://doi.org/10.1016/j.vaccine.2018.03.012
Autor:
Jonathan Hartzel, Michael J. Dallas, Luwy Musey, Rocio D. Marchese, Ajoke Sobanjo-ter Meulen, Steven D. Folkerth, John A. Hoekstra, Patricia A. Hoover, Jon E. Stek, Richard D. McFetridge, Wendy J. Watson, Donna M. Zacholski
Publikováno v:
Vaccine. 33(24)
Background Pneumococcal disease remains an important health priority despite successful implementation of pneumococcal conjugate vaccines (PCVs) in infant immunization programs, mainly due to the emergence of diseases caused by serotypes not included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f88a24cf8571bc51aa6498dfb4605b1
https://pubmed.ncbi.nlm.nih.gov/25913828
https://pubmed.ncbi.nlm.nih.gov/25913828